First gene-editing therapy recommended by NICE to treat people with beta thalassaemia NHS England said that around 460 patients aged 12 years and over could benefit from the treatment.…
Changes in migraine treatment: how new classes of drugs can provide additional options for patients and prescribers This episode of The PJ Pod looks at recent changes to National Institute for Health and Care Excellence guidance on the treatment of acute and chronic migraine and what pharmacists should expect from the new class of gepant drugs.…
More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
How we recycled over 20,000 inhalers so far in East Kent NHS Kent and Medway Integrated Care Board explains how an inhaler recycling scheme was set up as a collaborative working project with biopharmaceutical company Chiesi.…
NSAID prescribing in high-risk groups is a major source of avoidable harm, study finds The study estimated that the practice could have caused more than 6,000 lost years of good health across England over a ten-year period.…
MHRA approves semaglutide to prevent cardiovascular events in overweight and obese adults The approval is based on data from a trial that demonstrated how semaglutide lowered the incidence of major adverse cardiovascular events compared with placebo.…
People with substance use disorders need more compassion from community pharmacy Several factors impact how services are delivered across integrated care boards that offer NHS Inclusion drug treatment services, making it increasingly difficult for people with substance use disorders to access the care they need when and where they need it.…
Draft NICE guidance recommends ‘at-home’ pill for advance prostate cancer The National institute of Health and Care Excellence says up to 40,000 people in England could benefit from relugolix (Orgovyx; Accord).…
Sepsis: diagnosis and management How to manage suspected sepsis to minimise risk to patients while supporting efforts to improve antimicrobial stewardship.…
Paediatric arrhythmias: pathophysiology, types and pharmaceutical management While many arrhythmias in children are harmless, it is vital to distinguish between the different types to ensure that potentially harmful ones are identified early and treatment plans are optimised for the patient.…
